| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.02e-05 | 127 | 164 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP8B3 DHX36 WAPL ATRX DNAH10 CENPE ZGRF1 SPO11 SMARCAD1 DNAH7 ABCA8 HELB MCM9 MACF1 KIF13A DNAH9 | 4.80e-05 | 614 | 164 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.36e-05 | 262 | 164 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity | 2.00e-04 | 3 | 164 | 2 | GO:0061731 | |
| GeneOntologyMolecularFunction | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 2.00e-04 | 3 | 164 | 2 | GO:0004748 | |
| GeneOntologyMolecularFunction | microtubule binding | 2.39e-04 | 308 | 164 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.77e-04 | 70 | 164 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP8B3 DHX36 ATRX DNAH10 SMARCAD1 DNAH7 ABCA8 HELB MCM9 MACF1 KIF13A DNAH9 | 2.95e-04 | 441 | 164 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.05e-04 | 18 | 164 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 ATP8B3 DHX36 ATRX DNAH10 SMARCAD1 DNAH7 ABCA8 OPA1 HELB ADPRM CANT1 MCM9 MACF1 KIF13A DNAH9 RAB5A | 5.56e-04 | 839 | 164 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 ATP8B3 DHX36 ATRX DNAH10 SMARCAD1 DNAH7 ABCA8 OPA1 HELB ADPRM CANT1 MCM9 MACF1 KIF13A DNAH9 RAB5A | 5.64e-04 | 840 | 164 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 ATP8B3 DHX36 ATRX DNAH10 SMARCAD1 DNAH7 ABCA8 OPA1 HELB ADPRM CANT1 MCM9 MACF1 KIF13A DNAH9 RAB5A | 5.64e-04 | 840 | 164 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 6.60e-04 | 5 | 164 | 2 | GO:0016728 | |
| GeneOntologyMolecularFunction | tubulin binding | DCDC1 CENPE MDM1 SPIRE1 OPA1 HAUS8 PPARGC1A CGN MACF1 KIF13A NIN | 8.44e-04 | 428 | 164 | 11 | GO:0015631 |
| GeneOntologyBiologicalProcess | microtubule-based process | SPAG1 CATSPERE ATRX DNAH10 CENPE KIZ MDM1 SPIRE1 DNAAF11 DNAH7 OPA1 HAUS8 AUNIP CGN RNASE10 TEKT1 MACF1 SPAG17 KIF13A PPP2R3C DNAH9 PCNT WDR72 NIN | 3.44e-06 | 1058 | 164 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | double-strand break repair | ZGRF1 SPO11 SPIRE1 SMARCAD1 TEX15 KDM4E HELB AUNIP MCM9 C1QBP PRKDC | 5.90e-05 | 324 | 164 | 11 | GO:0006302 |
| GeneOntologyBiologicalProcess | DNA repair | ATRX ZGRF1 POLG RRM2B SPO11 SPIRE1 SMARCAD1 TEX15 KDM4E CEP164 HELB ALKBH1 AUNIP MCM9 C1QBP PRKDC | 6.21e-05 | 648 | 164 | 16 | GO:0006281 |
| GeneOntologyBiologicalProcess | cell cycle process | KNTC1 WAPL DCDC1 ATRX CENPE KIZ RRM2B SPTBN1 MDM1 SPO11 SPIRE1 SMARCAD1 TEX15 RRM2 BIRC6 MELK HAUS8 SYCP2 AUNIP MTA3 ANAPC2 PRKDC TAF1 KIF13A PCNT NIN | 7.10e-05 | 1441 | 164 | 26 | GO:0022402 |
| GeneOntologyCellularComponent | microtubule | KNTC1 DCDC1 DNAH10 CENPE MDM1 DNAH7 OPA1 GRIP1 HAUS8 TEKT1 MACF1 SPAG17 KIF13A DNAH9 PCNT NIN | 5.69e-06 | 533 | 166 | 16 | GO:0005874 |
| GeneOntologyCellularComponent | ribonucleoside-diphosphate reductase complex | 1.87e-04 | 3 | 166 | 2 | GO:0005971 | |
| Domain | RNR-rel | 7.39e-05 | 2 | 161 | 2 | IPR012348 | |
| Domain | RNR_small_fam | 7.39e-05 | 2 | 161 | 2 | IPR000358 | |
| Domain | RNR_small | 7.39e-05 | 2 | 161 | 2 | IPR033909 | |
| Domain | - | 7.39e-05 | 2 | 161 | 2 | 1.10.620.20 | |
| Domain | RNR_small_AS | 7.39e-05 | 2 | 161 | 2 | IPR030475 | |
| Domain | Ribonuc_red_sm | 7.39e-05 | 2 | 161 | 2 | PF00268 | |
| Domain | RIBORED_SMALL | 7.39e-05 | 2 | 161 | 2 | PS00368 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.13e-04 | 14 | 161 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.13e-04 | 14 | 161 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.13e-04 | 14 | 161 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.13e-04 | 14 | 161 | 3 | PF08393 | |
| Domain | MT | 2.13e-04 | 14 | 161 | 3 | PF12777 | |
| Domain | AAA_8 | 2.13e-04 | 14 | 161 | 3 | PF12780 | |
| Domain | DHC_fam | 2.65e-04 | 15 | 161 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.65e-04 | 15 | 161 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.65e-04 | 15 | 161 | 3 | IPR004273 | |
| Domain | MAM_1 | 3.24e-04 | 16 | 161 | 3 | PS00740 | |
| Domain | FN3 | 3.37e-04 | 199 | 161 | 8 | PS50853 | |
| Domain | MAM | 3.91e-04 | 17 | 161 | 3 | SM00137 | |
| Domain | MAM | 4.66e-04 | 18 | 161 | 3 | PF00629 | |
| Domain | MAM_dom | 4.66e-04 | 18 | 161 | 3 | IPR000998 | |
| Domain | MAM_2 | 4.66e-04 | 18 | 161 | 3 | PS50060 | |
| Domain | FN3_dom | 4.68e-04 | 209 | 161 | 8 | IPR003961 | |
| Domain | KIND_dom | 7.26e-04 | 5 | 161 | 2 | IPR011019 | |
| Domain | KIND | 7.26e-04 | 5 | 161 | 2 | SM00750 | |
| Domain | KIND | 7.26e-04 | 5 | 161 | 2 | PS51377 | |
| Domain | Spectrin | 9.81e-04 | 23 | 161 | 3 | PF00435 | |
| Domain | P-loop_NTPase | DHX36 ATRX DNAH10 CENPE ZGRF1 SMARCAD1 DNAH7 ABCA8 OPA1 HELB NWD2 MCM9 IFI44L DSEL KIF13A DNAH9 RAB5A | 1.06e-03 | 848 | 161 | 17 | IPR027417 |
| Domain | WD40_repeat_dom | 1.12e-03 | 297 | 161 | 9 | IPR017986 | |
| Domain | FN3 | 1.13e-03 | 185 | 161 | 7 | SM00060 | |
| Pubmed | DMTF1 EPRS1 WAPL ATRX POLG SPTBN1 CLDND1 PSMD1 SPIRE1 CRTC1 SEC31A PPARGC1A ZNF24 CANT1 UBAP2L NKAPD1 ARFGAP1 NFXL1 TRAPPC10 MACF1 KIF13A NFAT5 VPS13B PCNT | 7.22e-10 | 1084 | 170 | 24 | 11544199 | |
| Pubmed | DHX36 NPEPPS SPTAN1 SPTBN1 PSMD1 BIRC6 WDR3 USP5 UBAP2L CGN MACF1 LTA4H PRKDC NUP93 GCN1 VDAC1 PCNT | 2.59e-08 | 653 | 170 | 17 | 22586326 | |
| Pubmed | KCTD12 KNTC1 HIP1 KRT18 COG7 NPEPPS SPTAN1 SPTBN1 ISL2 PSMD1 IFIT3 SLC3A2 WDR3 USP5 UBAP2L ARFGAP1 TMEM209 C1QBP TRAPPC10 IFI44L PRKDC NUP93 HCFC2 GCN1 VDAC1 | 3.95e-08 | 1440 | 170 | 25 | 30833792 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | GPI DHX36 WAPL CENPE TNRC6B BIRC6 SLC3A2 ZNF24 ARFGAP1 MTMR3 NIN | 4.24e-08 | 247 | 170 | 11 | 32989298 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GPI DHX36 EPRS1 WAPL KRT18 NPEPPS SPTAN1 SPTBN1 PSMD1 SMARCAD1 SEC31A RRM2 BIRC6 MELK WDR59 SLC3A2 WDR3 ALKBH1 USP5 NFXL1 MACF1 PRKDC NUP93 GCN1 | 5.11e-08 | 1353 | 170 | 24 | 29467282 |
| Pubmed | KCTD12 EPRS1 SPTBN1 TNRC6B PSMD1 SEC31A JMJD1C OPA1 SLC3A2 GRIP1 UBAP2L ARFGAP1 C1QBP MACF1 PRKDC GCN1 VDAC1 | 8.27e-08 | 708 | 170 | 17 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPI KCTD12 KNTC1 DHX36 EPRS1 WAPL ATRX DNAH10 NPEPPS SPTAN1 SPTBN1 PSMD1 SMARCAD1 SEC31A OPA1 SLC3A2 WDR3 UBAP2L C1QBP FGD5 PRKDC NUP93 GCN1 VDAC1 | 1.33e-07 | 1425 | 170 | 24 | 30948266 |
| Pubmed | 1.81e-07 | 225 | 170 | 10 | 12168954 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPI KCTD12 EPRS1 WAPL AFTPH ATRX KRT18 TNRC6B SLC3A2 ORC2 UBAP2L ARFGAP1 C1QBP MACF1 LTA4H PRKDC GCN1 VDAC1 PCNT | 1.81e-07 | 934 | 170 | 19 | 33916271 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | WAPL ATRX SPTAN1 SPTBN1 PSMD1 SMARCAD1 MELK ORC2 ANAPC2 MACF1 PRKDC NUP93 GCN1 ARAP1 PCNT | 2.02e-07 | 582 | 170 | 15 | 20467437 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | AFTPH CENPE KIZ PKD1L1 TNRC6B CRTC1 RRM2 DNAH7 CEP164 GRIP1 WDR3 HAUS8 ARFGAP1 CGN TMEM209 NUP93 PCNT NIN | 2.29e-07 | 853 | 170 | 18 | 28718761 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 2.70e-07 | 235 | 170 | 10 | 28378594 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EPRS1 WAPL AFTPH ATRX SPTAN1 SPTBN1 ISL2 PSMD1 POU2F1 SMARCAD1 PASK UBAP2L ARFGAP1 TRAPPC10 PRKDC MED13 VDAC1 | 2.90e-07 | 774 | 170 | 17 | 15302935 |
| Pubmed | EPRS1 WAPL ATRX POLG SPTAN1 SPTBN1 PSMD1 SMARCAD1 SEC31A DSCAML1 WDR59 WDR3 MTA3 SACS HPS4 ZNF197 MTMR3 MACF1 PRKDC TAF1 MED13 PCNT | 3.54e-07 | 1285 | 170 | 22 | 35914814 | |
| Pubmed | DHX36 WAPL SPIRE1 CRTC1 MELK PASK MTA3 USP38 HPS4 ANAPC2 NUP93 MED13 ARAP1 NIN | 3.82e-07 | 529 | 170 | 14 | 14621295 | |
| Pubmed | EPRS1 COG7 SPTAN1 SPTBN1 PSMD1 SEC31A RRM2 SLC3A2 WDR3 USP5 C1QBP PRKDC NUP93 GCN1 VDAC1 | 6.45e-07 | 638 | 170 | 15 | 33239621 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 WAPL ATRX SPTAN1 SPTBN1 SMARCAD1 USP5 UBAP2L PRKDC TAF1 GCN1 | 8.15e-07 | 332 | 170 | 11 | 32786267 |
| Pubmed | PRUNE2 KCTD12 KNTC1 BIRC6 JMJD1C ABCA8 WDR59 SACS CGN MACF1 DDHD2 POM121B DHTKD1 | 1.05e-06 | 493 | 170 | 13 | 15368895 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | GPI DHX36 NPEPPS SPTAN1 SPTBN1 PSMD1 BIRC6 USP5 UBAP2L PRKDC GCN1 | 1.15e-06 | 344 | 170 | 11 | 30333137 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AFTPH KRT18 SPTAN1 SPTBN1 SPIRE1 CRTC1 RRM2 MELK DNAH7 WDR59 GRIP1 HAUS8 ARFGAP1 CGN MACF1 NUP93 KIF13A | 1.25e-06 | 861 | 170 | 17 | 36931259 |
| Pubmed | 1.81e-06 | 167 | 170 | 8 | 25659891 | ||
| Pubmed | EPRS1 PSMD1 SEC31A BIRC6 SLC3A2 USP5 TMEM209 KYAT3 LTA4H PRKDC NUP93 GCN1 RAB5A | 2.53e-06 | 534 | 170 | 13 | 35032548 | |
| Pubmed | EPRS1 WAPL SPTAN1 TNRC6B JMJD1C SLC3A2 UBAP2L ARFGAP1 CGN PRKDC TAF1 GCN1 RGPD5 | 3.42e-06 | 549 | 170 | 13 | 38280479 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | GPI KCTD12 EPRS1 KRT18 NPEPPS SPTAN1 SPTBN1 PSMD1 SEC31A USP5 UBAP2L C1QBP MACF1 LTA4H PRKDC NUP93 HCFC2 GCN1 VDAC1 | 3.90e-06 | 1149 | 170 | 19 | 35446349 |
| Pubmed | WAPL COG7 NPEPPS PSMD1 SEC31A OPA1 WDR3 HAUS8 MTA3 UBAP2L ANAPC2 C1QBP NUP93 | 4.24e-06 | 560 | 170 | 13 | 35241646 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | GPI EPRS1 NPEPPS SPTAN1 SPTBN1 OPA1 SLC3A2 CGN PRKDC NUP93 GCN1 VDAC1 | 4.47e-06 | 477 | 170 | 12 | 31300519 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.19e-06 | 256 | 170 | 9 | 33397691 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KCTD12 KNTC1 DHX36 EPRS1 ATRX KRT18 NPEPPS PSMD1 SPIRE1 JMJD1C OPA1 SLC3A2 PASK CGN PRKAB2 LTA4H NUP93 GCN1 RAB5A VDAC1 | 5.20e-06 | 1284 | 170 | 20 | 17353931 |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 5.52e-06 | 258 | 170 | 9 | 21081666 | |
| Pubmed | TNRC6B SMARCAD1 ZHX2 CSMD3 OPA1 UBAP2L MTMR3 MACF1 NFAT5 VPS13B PCNT | 5.77e-06 | 407 | 170 | 11 | 12693553 | |
| Pubmed | GPI EPRS1 KRT18 NPEPPS SPTAN1 SPTBN1 TNRC6B PSMD1 SEC31A UBAP2L NUP93 GCN1 | 6.37e-06 | 494 | 170 | 12 | 26831064 | |
| Pubmed | DHX36 ATRX DNAH10 KLF6 SPTAN1 SPTBN1 TNRC6B ISL2 PSMD1 POU2F1 ZHX2 JMJD1C ZNF24 MTA3 UBAP2L ARFGAP1 C1QBP TAF1 NUP93 HCFC2 VDAC1 | 7.25e-06 | 1429 | 170 | 21 | 35140242 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 7.66e-06 | 203 | 170 | 8 | 22083510 | |
| Pubmed | KCTD12 RASGRF1 SPTAN1 SPTBN1 PSMD1 SACS UBAP2L ARFGAP1 MACF1 VDAC1 | 8.89e-06 | 347 | 170 | 10 | 17114649 | |
| Pubmed | ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. | 9.43e-06 | 9 | 170 | 3 | 21275903 | |
| Pubmed | USP7 controls NGN3 stability and pancreatic endocrine lineage development. | 9.77e-06 | 58 | 170 | 5 | 37117185 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GPI EPRS1 NPEPPS SPTAN1 SPTBN1 PSMD1 SLC3A2 USP5 MACF1 LTA4H PRKDC SPAG17 GCN1 RAB5A VDAC1 | 1.11e-05 | 807 | 170 | 15 | 30575818 |
| Pubmed | 1.22e-05 | 360 | 170 | 10 | 33111431 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPI EPRS1 KRT18 NPEPPS PSMD1 SLC3A2 WDR3 ZNF24 SACS UBAP2L CGN C1QBP MACF1 PRKDC NUP93 GCN1 PCNT | 1.23e-05 | 1024 | 170 | 17 | 24711643 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | RASGRF1 CENPE RRM2B PKD1L1 CRTC1 JMJD1C SYCP2 MACF1 PRKDC DNAH9 | 1.25e-05 | 361 | 170 | 10 | 26167880 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PIGN SPAG1 RRM2B SEC31A BIRC6 ALKBH1 USP5 UBAP2L ARFGAP1 ANAPC2 MACF1 KIF13A EPHA7 WDR72 | 1.32e-05 | 719 | 170 | 14 | 35337019 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 EOGT ATRX NPEPPS KIZ POLG FRMPD2 TNRC6B PSMD1 SPIRE1 ZHX2 JMJD1C MTA3 UBAP2L KYAT3 MACF1 NFAT5 VPS13B NSMAF ARAP1 PCNT | 1.34e-05 | 1489 | 170 | 21 | 28611215 |
| Pubmed | KNTC1 SPTAN1 TNRC6B BIRC6 GRIP1 CGN MTMR3 C1QBP TRAPPC10 PRKDC NIN | 1.36e-05 | 446 | 170 | 11 | 24255178 | |
| Pubmed | GPI NPEPPS PSMD1 POU2F1 OPA1 SLC3A2 ZNF100 ZNF506 LTA4H NUP93 DHTKD1 | 1.50e-05 | 451 | 170 | 11 | 36168627 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | GPI KNTC1 WAPL CENPE COG7 KIZ ORC2 HAUS8 ANAPC2 C1QBP PRKDC NUP93 PPP2R3C GCN1 VPS13B ARAP1 VDAC1 RGPD5 | 1.58e-05 | 1155 | 170 | 18 | 20360068 |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 1.84e-05 | 11 | 170 | 3 | 17607528 | |
| Pubmed | GPI KRT18 SPTAN1 PSMD1 SLC3A2 WDR3 C1QBP PRKDC NUP93 GCN1 VDAC1 | 1.92e-05 | 463 | 170 | 11 | 34901782 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPI DHX36 EPRS1 KRT18 SPTAN1 SPTBN1 TNRC6B PSMD1 SMARCAD1 SEC31A BIRC6 OPA1 SLC3A2 USP5 UBAP2L C1QBP MACF1 PRKDC GCN1 VDAC1 | 2.12e-05 | 1415 | 170 | 20 | 28515276 |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 16385466 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 14612514 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 15322079 | ||
| Pubmed | Identification of a mouse brain beta-spectrin cDNA and distribution of its mRNA in adult tissues. | 2.38e-05 | 2 | 170 | 2 | 1742606 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 26191154 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 25878246 | ||
| Pubmed | Spectrin-actin interaction is required for neurite extension in NB 2a/dl neuroblastoma cells. | 2.38e-05 | 2 | 170 | 2 | 8776664 | |
| Pubmed | Deregulation of pancreas-specific oxidoreductin ERO1β in the pathogenesis of diabetes mellitus. | 2.38e-05 | 2 | 170 | 2 | 24469402 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 31039348 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 18579525 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23250358 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 23936397 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 21965764 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 20484015 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 14578206 | ||
| Pubmed | Ribonucleotide reductase subunit switching in hepatoblastoma drug response and relapse. | 2.38e-05 | 2 | 170 | 2 | 36882565 | |
| Pubmed | Redox property of ribonucleotide reductase small subunit M2 and p53R2. | 2.38e-05 | 2 | 170 | 2 | 19082948 | |
| Pubmed | Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. | 2.38e-05 | 2 | 170 | 2 | 16879257 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 31387996 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 22729384 | ||
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 8406479 | ||
| Pubmed | Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. | 2.38e-05 | 2 | 170 | 2 | 22357654 | |
| Pubmed | 2.38e-05 | 2 | 170 | 2 | 11280766 | ||
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 2.62e-05 | 118 | 170 | 6 | 27377895 | |
| Pubmed | KNTC1 EPRS1 SPAG1 ATRX KRT18 COL20A1 SPTAN1 SPTBN1 ANKRD30B PSMD1 SLC3A2 SACS ANKRD30A NFXL1 MACF1 PRKDC SPAG17 MED13 PCNT RGPD5 | 2.77e-05 | 1442 | 170 | 20 | 35575683 | |
| Pubmed | 2.82e-05 | 72 | 170 | 5 | 36376293 | ||
| Pubmed | GPI EPRS1 HIP1 NPEPPS PSMD1 SEC31A SLC3A2 USP5 MTA3 ARFGAP1 C1QBP LTA4H PRKDC NUP93 GCN1 | 2.96e-05 | 878 | 170 | 15 | 37223481 | |
| Pubmed | KRT18 SPTAN1 SPTBN1 PSMD1 CRTC1 SEC31A HPS4 MACF1 PRKDC TAF1 GCN1 | 2.98e-05 | 486 | 170 | 11 | 20936779 | |
| Pubmed | 3.05e-05 | 320 | 170 | 9 | 28685749 | ||
| Pubmed | 3.13e-05 | 180 | 170 | 7 | 24104479 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 KCTD12 KNTC1 EPRS1 KRT18 COG7 NPEPPS SPTAN1 SPTBN1 PSMD1 SMARCAD1 BIRC6 USP5 MTA3 ARFGAP1 C1QBP MACF1 PRKDC KIF13A GCN1 | 3.15e-05 | 1455 | 170 | 20 | 22863883 |
| Pubmed | Cep120 and TACCs control interkinetic nuclear migration and the neural progenitor pool. | 3.17e-05 | 13 | 170 | 3 | 17920017 | |
| Pubmed | 3.20e-05 | 322 | 170 | 9 | 26514267 | ||
| Pubmed | 3.67e-05 | 76 | 170 | 5 | 27542412 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | SPTAN1 SPTBN1 SMARCAD1 SLC3A2 DMXL1 HAUS8 PRKDC CCDC180 DNAH9 | 4.15e-05 | 333 | 170 | 9 | 32665550 |
| Pubmed | AFTPH ERO1B ATRX SPTAN1 SPTBN1 SMARCAD1 SLC3A2 DMXL1 WDR3 PASK SACS TMEM209 NFXL1 C1QBP MACF1 DDHD2 VPS13B PCNT EPHA7 NIN | 4.26e-05 | 1487 | 170 | 20 | 33957083 | |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | 4.71e-05 | 422 | 170 | 10 | 27342126 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DHX36 EPRS1 NPEPPS TNRC6B PSMD1 RRM2 BIRC6 OPA1 SLC3A2 WDR3 TMEM209 NFXL1 C1QBP PRKDC NUP93 GCN1 VDAC1 RGPD5 | 4.76e-05 | 1257 | 170 | 18 | 37317656 |
| Pubmed | EPRS1 KRT18 SPTBN1 SEC31A SLC3A2 UBAP2L C1QBP MACF1 PRKDC NUP93 GCN1 ARAP1 VDAC1 | 4.87e-05 | 707 | 170 | 13 | 19738201 | |
| Pubmed | 5.00e-05 | 15 | 170 | 3 | 26320552 | ||
| Pubmed | 5.00e-05 | 15 | 170 | 3 | 12393188 | ||
| Pubmed | 6.05e-05 | 271 | 170 | 8 | 26816005 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 WAPL KRT18 PSMD1 SEC31A OPA1 SLC3A2 USP5 ANAPC2 TMEM209 NFXL1 PRKDC NUP93 GCN1 VDAC1 | 6.54e-05 | 942 | 170 | 15 | 31073040 |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 6.55e-05 | 139 | 170 | 6 | 25476789 | |
| Pubmed | KNTC1 WAPL CENPE TNRC6B BIRC6 MELK JMJD1C WDR59 SLC3A2 HAUS8 AUNIP TMEM209 NFXL1 | 7.02e-05 | 733 | 170 | 13 | 34672954 | |
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 32161153 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 20395428 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 17486094 | ||
| Pubmed | 7.10e-05 | 3 | 170 | 2 | 33450350 | ||
| Pubmed | Tissue factor binds to and inhibits interferon-α receptor 1 signaling. | 7.10e-05 | 3 | 170 | 2 | 38141610 | |
| Pubmed | CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis. | 7.10e-05 | 3 | 170 | 2 | 22426420 | |
| Pubmed | DNA-PK phosphorylation sites on Oct-1 promote cell survival following DNA damage. | 7.10e-05 | 3 | 170 | 2 | 17213819 | |
| Interaction | TES interactions | GPI EPRS1 KRT18 SPTAN1 SPTBN1 SLC3A2 GRIP1 KYAT3 MACF1 PRKDC NUP93 GCN1 ARAP1 | 4.47e-06 | 332 | 168 | 13 | int:TES |
| Interaction | TTC3 interactions | 9.57e-06 | 124 | 168 | 8 | int:TTC3 | |
| Cytoband | 19p13.11 | 1.62e-04 | 73 | 170 | 4 | 19p13.11 | |
| GeneFamily | Dyneins, axonemal | 1.25e-04 | 17 | 106 | 3 | 536 | |
| GeneFamily | EF-hand domain containing|Spectrins | 7.01e-04 | 7 | 106 | 2 | 1113 | |
| GeneFamily | WD repeat domain containing | 8.92e-04 | 262 | 106 | 7 | 362 | |
| GeneFamily | Sterile alpha motif domain containing | 1.78e-03 | 88 | 106 | 4 | 760 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | DMTF1 KCTD12 EPRS1 HIP1 WAPL ERO1B ATRX NPEPPS CYBC1 SPTBN1 KRBOX4 SEC31A WDR59 OPA1 DMXL1 WDR3 SACS UBAP2L NKAPD1 C1QBP TRAPPC10 KYAT3 MACF1 PRKDC PPP2R3C NFAT5 RAB5A | 1.88e-08 | 1215 | 169 | 27 | M41122 |
| Coexpression | FISCHER_DREAM_TARGETS | KNTC1 CENPE ZGRF1 MDM1 POU2F1 RRM2 BIRC6 MELK OPA1 SLC3A2 IFNAR1 ORC2 PASK HAUS8 ZNF24 ZNF100 AUNIP TMEM209 PRKDC NUP93 DHTKD1 PCNT | 3.12e-07 | 969 | 169 | 22 | M149 |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 7.12e-07 | 199 | 169 | 10 | M6839 | |
| Coexpression | FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN | 6.13e-06 | 70 | 169 | 6 | M5370 | |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_UP | 6.13e-06 | 199 | 169 | 9 | M4865 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP | 6.13e-06 | 199 | 169 | 9 | M7652 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP | 6.39e-06 | 200 | 169 | 9 | M3577 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | DCDC1 DNAH10 FRMPD2 ECT2L ZC2HC1C DNAAF11 DNAH7 RSPH10B2 TEKT1 SPAG17 DNAH9 | 7.22e-06 | 317 | 169 | 11 | M40298 |
| Coexpression | MTOR_UP.N4.V1_DN | 2.70e-05 | 184 | 169 | 8 | M2756 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.75e-05 | 250 | 169 | 9 | M11318 | |
| Coexpression | BILD_SRC_ONCOGENIC_SIGNATURE | 3.97e-05 | 59 | 169 | 5 | M116 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 4.08e-05 | 195 | 169 | 8 | M9808 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN | 4.39e-05 | 197 | 169 | 8 | M5317 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | PRUNE2 SPAG1 DCDC1 DNAH10 ZNF674 FRMPD2 MDM1 ECT2L DNAH7 MACF1 SPAG17 DNAH9 | 4.60e-05 | 459 | 169 | 12 | M39136 |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 4.71e-05 | 199 | 169 | 8 | M8381 | |
| Coexpression | GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 4.71e-05 | 199 | 169 | 8 | M3070 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 DHX36 EPRS1 CENPE RRM2B SMARCAD1 OPA1 DMXL1 PPARGC1A DTWD1 SACS ARFGAP1 ENOX2 NIN | 9.58e-05 | 656 | 169 | 14 | M18979 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ERO1B SPTAN1 CLDND1 JMJD1C OPA1 ZNF24 USP38 CANT1 UBAP2L MCM9 TRAPPC10 MED13 NSMAF RGPD5 | 1.39e-04 | 680 | 169 | 14 | M41089 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | WAPL ATRX KLF6 CENPE NPEPPS ZHX2 MELK OPA1 ORC2 SACS MTMR3 MACF1 MED13 VPS13B NSMAF PCNT | 1.41e-04 | 856 | 169 | 16 | M4500 |
| Coexpression | RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN | 1.46e-04 | 368 | 169 | 10 | M1859 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 AFTPH KIZ ZGRF1 SPO11 TEX15 MELK ZFAND4 DMXL1 ORC2 SYCP2 AUNIP MTA3 TMEM209 NFXL1 PRKDC TAF1 NUP93 DDHD2 ZMYM6 | 4.20e-06 | 820 | 161 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | KNTC1 ZGRF1 SPO11 TEX15 MELK ZFAND4 SYCP2 AUNIP NFXL1 PRKDC TAF1 NUP93 DDHD2 | 7.94e-06 | 385 | 161 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | DHX36 AFTPH ERO1B ATRX COG7 SPTBN1 SPO11 TEX15 BIRC6 DNAH7 EGFL6 DMXL1 IFNAR1 SYCP2 SACS CGN HCFC2 NFAT5 ZMYM6 | 9.91e-06 | 795 | 161 | 19 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DHX36 CRLF1 ERO1B ATRX COG7 SPTBN1 SPO11 TEX15 BIRC6 DNAH7 EGFL6 DMXL1 IFNAR1 SYCP2 SACS CGN HCFC2 NFAT5 | 2.65e-05 | 778 | 161 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | KNTC1 WAPL ZGRF1 MDM1 SPO11 TEX15 MELK HELB ORC2 PASK SYCP2 AUNIP MTA3 NFXL1 PRKDC TAF1 NUP93 DDHD2 | 5.41e-05 | 822 | 161 | 18 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | EPRS1 HIP1 WAPL CENPE POLG SPTAN1 POU2F1 SPIRE1 SMARCAD1 ZHX2 BIRC6 OPA1 PRKDC PCNT | 5.63e-05 | 532 | 161 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | PIGN WAPL ERO1B KRT18 TEX15 DNAH7 EGFL6 IFNAR1 DTWD1 MTA3 SACS CGN NFXL1 KYAT3 NFAT5 EPHA7 NIN | 1.34e-04 | 804 | 161 | 17 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.42e-04 | 104 | 161 | 6 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.64e-04 | 203 | 161 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.66e-04 | 107 | 161 | 6 | gudmap_developingGonad_e16.5_ovary_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.82e-04 | 15 | 161 | 3 | gudmap_developingGonad_e11.5_testes and mesonephros_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 1.92e-04 | 38 | 161 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | ATRX CENPE BIRC6 CEP164 PPARGC1A ZNF24 MCM9 NFAT5 GCN1 MED13 | 2.72e-04 | 339 | 161 | 10 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | ATRX COG7 SPTBN1 SPO11 TEX15 BIRC6 JMJD1C EGFL6 DMXL1 IFNAR1 SYCP2 SACS UBAP2L NFXL1 NFAT5 DHTKD1 | 2.82e-04 | 776 | 161 | 16 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | fallopian tube | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 RSPH10B2 TEKT1 SPAG17 CCDC180 DNAH9 | 2.92e-04 | 408 | 161 | 11 | fallopian tube |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | KRT18 TEX15 DNAH7 EGFL6 IFNAR1 MTA3 CGN NFXL1 KYAT3 NFAT5 EPHA7 | 3.31e-04 | 414 | 161 | 11 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 3.35e-04 | 171 | 161 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_200 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 DCDC1 DNAH10 ECT2L DNAAF11 DNAH7 TEKT1 FRMPD2B SPAG17 CCDC180 DNAH9 | 2.32e-10 | 193 | 170 | 11 | e1b76102f812c433195d1e8811fdd3293a7bc22e |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SPAG1 DCDC1 DNAH10 FRMPD2 ECT2L DNAH7 RSPH10B2 TEKT1 SPAG17 DNAH9 | 2.10e-09 | 181 | 170 | 10 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN DNAH10 MDGA2 CSMD3 DSCAML1 PPARGC1A SYCP2 SPAG17 DNAH9 EPHA7 | 2.47e-09 | 184 | 170 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN DNAH10 MDGA2 CSMD3 DSCAML1 PPARGC1A SYCP2 SPAG17 DNAH9 EPHA7 | 2.47e-09 | 184 | 170 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ZAN DNAH10 MDGA2 CSMD3 DSCAML1 PPARGC1A SYCP2 SPAG17 DNAH9 EPHA7 | 2.47e-09 | 184 | 170 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | DCDC1 DNAH10 FRMPD2 ECT2L DNAH7 DSCAML1 RSPH10B2 TEKT1 SPAG17 DNAH9 | 2.60e-09 | 185 | 170 | 10 | 30f4980dee6cd5959655f8d74049f3bfb5312611 |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 2.74e-09 | 186 | 170 | 10 | 76033438426d8f9c72cd6691a7baf92104c9f03d |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | SPAG1 DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 DNAH9 | 3.72e-09 | 192 | 170 | 10 | be592e661367affced9ebe80849b466e6adb3a34 |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | SPAG1 DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 DNAH9 | 3.91e-09 | 193 | 170 | 10 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.11e-09 | 194 | 170 | 10 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 DCDC1 DNAH10 ECT2L DNAAF11 DNAH7 TEKT1 FRMPD2B SPAG17 DNAH9 | 4.32e-09 | 195 | 170 | 10 | 0e763f36786515698b593e5c93f6a56619c1242d |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.32e-09 | 195 | 170 | 10 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.32e-09 | 195 | 170 | 10 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.53e-09 | 196 | 170 | 10 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.53e-09 | 196 | 170 | 10 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.76e-09 | 197 | 170 | 10 | e453d085182364ca347cbcc9dc995c62c3353016 |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 4.76e-09 | 197 | 170 | 10 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 5.00e-09 | 198 | 170 | 10 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 CCDC180 DNAH9 | 5.50e-09 | 200 | 170 | 10 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | DCDC1 DNAH10 FRMPD2 ECT2L DNAH7 RSPH10B2 TEKT1 SPAG17 CCDC180 DNAH9 | 5.50e-09 | 200 | 170 | 10 | 31d75c26055177d656df1fbb10b764cebd61e122 |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | SPAG1 DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 DNAH9 | 5.50e-09 | 200 | 170 | 10 | 7cb3e3bd9e851ccb096e0a3471819471d85ebace |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | DCDC1 DNAH10 FRMPD2 ECT2L DNAH7 RSPH10B2 TEKT1 SPAG17 CCDC180 DNAH9 | 5.50e-09 | 200 | 170 | 10 | e1dce91c6c531bb212002a14705e496d77ad3490 |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | SPAG1 DCDC1 DNAH10 FRMPD2 ECT2L DNAAF11 DNAH7 TEKT1 SPAG17 DNAH9 | 5.50e-09 | 200 | 170 | 10 | 8441e289377215a6877640946fe3f6de1f456502 |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.70e-08 | 167 | 170 | 9 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.58e-08 | 182 | 170 | 9 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.32e-08 | 186 | 170 | 9 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.96e-08 | 189 | 170 | 9 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-08 | 191 | 170 | 9 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-08 | 191 | 170 | 9 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.43e-08 | 191 | 170 | 9 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.67e-08 | 192 | 170 | 9 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.93e-08 | 193 | 170 | 9 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.93e-08 | 193 | 170 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.93e-08 | 193 | 170 | 9 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.20e-08 | 194 | 170 | 9 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.20e-08 | 194 | 170 | 9 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.20e-08 | 194 | 170 | 9 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-08 | 194 | 170 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 6.20e-08 | 194 | 170 | 9 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 DCDC1 DNAH10 DNAAF11 DNAH7 FRMPD2B SPAG17 CCDC180 DNAH9 | 6.48e-08 | 195 | 170 | 9 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-08 | 195 | 170 | 9 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-08 | 195 | 170 | 9 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 DCDC1 DNAH10 DNAAF11 DNAH7 FRMPD2B SPAG17 CCDC180 DNAH9 | 6.48e-08 | 195 | 170 | 9 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | SPAG1 DCDC1 DNAH10 DNAAF11 DNAH7 FRMPD2B SPAG17 CCDC180 DNAH9 | 6.48e-08 | 195 | 170 | 9 | 3e70ee987d66d450062d5df3d7c733ccc7344470 |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | SPAG1 DNAH10 DNAAF11 DNAH7 TEKT1 FRMPD2B SPAG17 CCDC180 DNAH9 | 6.48e-08 | 195 | 170 | 9 | 60067b5359174f0d1a8b5748bfc0690762e9e740 |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-08 | 195 | 170 | 9 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.77e-08 | 196 | 170 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-08 | 196 | 170 | 9 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.77e-08 | 196 | 170 | 9 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.77e-08 | 196 | 170 | 9 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.77e-08 | 196 | 170 | 9 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.77e-08 | 196 | 170 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.77e-08 | 196 | 170 | 9 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-08 | 197 | 170 | 9 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-08 | 197 | 170 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.07e-08 | 197 | 170 | 9 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.07e-08 | 197 | 170 | 9 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-08 | 197 | 170 | 9 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-08 | 197 | 170 | 9 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.07e-08 | 197 | 170 | 9 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-08 | 199 | 170 | 9 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.71e-08 | 199 | 170 | 9 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | DNAH10 ECT2L ZC2HC1C DNAH7 TEKT1 FRMPD2B SPAG17 CCDC180 DNAH9 | 8.05e-08 | 200 | 170 | 9 | 4992dbf0514d674017315dbd20d91dfec0c608e9 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-08 | 200 | 170 | 9 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.17e-07 | 177 | 170 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.35e-07 | 178 | 170 | 8 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 4.35e-07 | 178 | 170 | 8 | d8e0a696bdd6af6422d72af0413f9dbd6bc02afa | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.54e-07 | 179 | 170 | 8 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-07 | 181 | 170 | 8 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-07 | 181 | 170 | 8 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.15e-07 | 182 | 170 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-07 | 182 | 170 | 8 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.15e-07 | 182 | 170 | 8 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-07 | 183 | 170 | 8 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-07 | 183 | 170 | 8 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-07 | 184 | 170 | 8 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.83e-07 | 185 | 170 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.83e-07 | 185 | 170 | 8 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.83e-07 | 185 | 170 | 8 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.83e-07 | 185 | 170 | 8 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 6.07e-07 | 186 | 170 | 8 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.32e-07 | 187 | 170 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.58e-07 | 188 | 170 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.58e-07 | 188 | 170 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.58e-07 | 188 | 170 | 8 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.58e-07 | 188 | 170 | 8 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.58e-07 | 188 | 170 | 8 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.85e-07 | 189 | 170 | 8 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.85e-07 | 189 | 170 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.85e-07 | 189 | 170 | 8 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 6.85e-07 | 189 | 170 | 8 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 6.85e-07 | 189 | 170 | 8 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.13e-07 | 190 | 170 | 8 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.13e-07 | 190 | 170 | 8 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 7.13e-07 | 190 | 170 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 7.13e-07 | 190 | 170 | 8 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.42e-07 | 191 | 170 | 8 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| Disease | MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME | 9.40e-05 | 3 | 166 | 2 | C0872218 | |
| Disease | Metastatic melanoma | 2.45e-04 | 54 | 166 | 4 | C0278883 | |
| Disease | Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 1 | 3.11e-04 | 5 | 166 | 2 | C1834846 | |
| Disease | chronic kidney disease | 3.86e-04 | 235 | 166 | 7 | EFO_0003884 | |
| Disease | age related macular degeneration (implicated_via_orthology) | 4.65e-04 | 6 | 166 | 2 | DOID:10871 (implicated_via_orthology) | |
| Disease | gamma-enolase measurement | 4.65e-04 | 6 | 166 | 2 | EFO_0021845 | |
| Disease | response to vaccine | 6.47e-04 | 122 | 166 | 5 | EFO_0004645 | |
| Disease | Abnormality of the eye | 6.49e-04 | 7 | 166 | 2 | C4316870 | |
| Disease | dentures | 6.63e-04 | 70 | 166 | 4 | EFO_0010078 | |
| Disease | dental caries, dentures | 6.63e-04 | 70 | 166 | 4 | EFO_0003819, EFO_0010078 | |
| Disease | Kartagener Syndrome | 1.00e-03 | 35 | 166 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.00e-03 | 35 | 166 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.00e-03 | 35 | 166 | 3 | C4317124 | |
| Disease | Megaconial Myopathies | 1.10e-03 | 9 | 166 | 2 | C0162668 | |
| Disease | Pleoconial Myopathies | 1.10e-03 | 9 | 166 | 2 | C0162669 | |
| Disease | Luft Disease | 1.10e-03 | 9 | 166 | 2 | C0949496 | |
| Disease | Situs ambiguous | 1.10e-03 | 9 | 166 | 2 | C1167664 | |
| Disease | Malignant neoplasm of breast | GPI CATSPERE KRT18 SPTAN1 POU2F1 LEPR SURF1 SLC6A5 MTMR3 ANKRD30A C1QBP MACF1 FGD5 DNAH9 VPS13B | 1.13e-03 | 1074 | 166 | 15 | C0006142 |
| Disease | ascending aortic diameter | 1.20e-03 | 140 | 166 | 5 | EFO_0021787 | |
| Disease | thalamus volume | 1.37e-03 | 85 | 166 | 4 | EFO_0006935 | |
| Disease | pancreatic hormone measurement | 1.37e-03 | 10 | 166 | 2 | EFO_0020621 | |
| Disease | cholelithiasis | 1.56e-03 | 88 | 166 | 4 | EFO_0004799 | |
| Disease | Mitochondrial Myopathies | 1.67e-03 | 11 | 166 | 2 | C0162670 | |
| Disease | Situs Inversus | 1.67e-03 | 11 | 166 | 2 | C0037221 | |
| Disease | hematocrit | DCDC1 ZAN KLF6 TNRC6B SPO11 SPIRE1 CRTC1 KRBOX4 CEP164 PPARGC1A AUNIP MTMR3 FGD5 NFAT5 | 1.79e-03 | 1011 | 166 | 14 | EFO_0004348 |
| Disease | Primary Ciliary Dyskinesia | 2.36e-03 | 47 | 166 | 3 | C4551720 | |
| Disease | response to antineoplastic agent | 2.40e-03 | 99 | 166 | 4 | GO_0097327 | |
| Disease | basophil percentage of leukocytes | 2.60e-03 | 243 | 166 | 6 | EFO_0007992 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 2.66e-03 | 49 | 166 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | sodium measurement | 2.77e-03 | 103 | 166 | 4 | EFO_0009282 | |
| Disease | Situs ambiguus | 3.15e-03 | 15 | 166 | 2 | C0266642 | |
| Disease | quinate measurement | 3.15e-03 | 15 | 166 | 2 | EFO_0021167 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.91e-03 | 264 | 166 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | Intellectual Disability | 3.93e-03 | 447 | 166 | 8 | C3714756 | |
| Disease | proprotein convertase subtilisin/kexin type 7 measurement | 4.05e-03 | 17 | 166 | 2 | EFO_0008270 | |
| Disease | hyperglycemia (implicated_via_orthology) | 4.05e-03 | 17 | 166 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 4.54e-03 | 18 | 166 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | disease free survival | 4.54e-03 | 18 | 166 | 2 | EFO_0000409 | |
| Disease | Chronic myeloproliferative disorder | 5.05e-03 | 19 | 166 | 2 | C1292778 | |
| Disease | puberty onset measurement | 5.52e-03 | 125 | 166 | 4 | EFO_0005677 | |
| Disease | renal system measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0004742 | |
| Disease | pars triangularis volume measurement | 5.59e-03 | 20 | 166 | 2 | EFO_0010321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FTEKWNTDNTLGTEI | 71 | P21796 | |
| DTLESAEDIFWKQAD | 106 | Q5NDL2 | |
| NNALAWEKTTSEDEK | 486 | Q8IUX8 | |
| AAESLQEADKWSTLS | 121 | P83436 | |
| SESKQKDDEENSWDF | 716 | Q9BXX2 | |
| QDQASWTLEELSKAV | 671 | Q9UJX6 | |
| PKDSDQFEWVTIEQS | 4111 | Q9NR09 | |
| EDTKQWVSQDFTLDA | 426 | Q5SY80 | |
| QLWLEFNSDTEGTDE | 1326 | Q7Z407 | |
| EANATEWKSSQRFSD | 171 | Q0P641 | |
| ESEWKDTNYTLNTDS | 216 | Q07021 | |
| SKEETQDLWEQSKEF | 136 | Q13686 | |
| QSKAWSLVDSADNSE | 331 | Q6ULP2 | |
| STLSNQSKEAFIDWA | 141 | Q86YB8 | |
| KQKDYEENSWDTESL | 676 | Q9BXX3 | |
| DKEFVSWQQDLEDSV | 56 | O43741 | |
| WLNEVLTFSDTNQEK | 221 | Q3LIE5 | |
| VTASSDKAFEDWLND | 156 | Q8N6T3 | |
| SERNVVEDNSWDTKS | 526 | Q008S8 | |
| LQDEDRNSAFTWKVQ | 96 | O60423 | |
| WKAFTEEEAETLVNQ | 466 | Q9P1Z9 | |
| DKSFETLADQTEWQS | 501 | Q9P1Z9 | |
| SIETSQLQSQDEKDW | 131 | Q96HY7 | |
| EVSAVSQAWFTTKED | 126 | Q9Y222 | |
| EDKSSAVDWSQSLIN | 1916 | Q9Y485 | |
| SVVFQDDSLELKWDS | 1956 | Q9Y485 | |
| AWISQAFDDDSALLK | 41 | Q9BU89 | |
| STNAENEKTWQEISD | 191 | Q9ULI1 | |
| DNQSEVADKTEDYLW | 401 | Q8N1F7 | |
| DITNEESFARAKNWV | 101 | P20339 | |
| LESDKSDWQATNTDL | 221 | Q99666 | |
| ESLNRDWSDQIDVTK | 226 | O14718 | |
| WITAKEDDLNSFNAT | 476 | P09960 | |
| KSNNWSLEDVTASDK | 351 | Q14680 | |
| RDEELSKESQETNWF | 256 | Q969Q6 | |
| EADSSNADWVTKQLN | 326 | P00751 | |
| AWARQSTSADVKDFE | 176 | Q5JQF8 | |
| KDDREEEFNTWVNNT | 751 | B2RC85 | |
| WALDESFLQRDSEKQ | 1471 | M0R2J8 | |
| WNLKELFFSDQTDQT | 741 | Q96RG2 | |
| ELDKYWSQQIEESTT | 266 | P05783 | |
| WTTLVSDSQEDKKNS | 296 | Q9Y5Z7 | |
| WAKDSQFLVSSVTDD | 191 | Q6ZNB6 | |
| DSLWFSLQKKNDTTE | 81 | Q53G44 | |
| KDSIISNANVKEFWD | 2226 | Q15652 | |
| DDSKFSEAVQTLLTW | 261 | Q16206 | |
| SQEELSTEWDTFIEQ | 131 | Q9NQG7 | |
| ADLDTESRAQEENTW | 111 | Q8WVQ1 | |
| SRGNFSNEEWKELET | 71 | P06126 | |
| SFWSEEIKFDTEIQA | 316 | P17181 | |
| INDWRKFKLESQDSD | 26 | P20941 | |
| FKAEDTNSAQRWIEA | 1441 | Q6ZNL6 | |
| RLAWDTENTSEDVQK | 441 | Q8TC05 | |
| DSKETWIPFNSEDSQ | 51 | O94830 | |
| AEEFLLTDNSAIWQT | 676 | P54098 | |
| DISGSLFEESTKQWN | 136 | B2RXH2 | |
| KDSFSNSSWEIEAQA | 1021 | P48357 | |
| GSSWIEFLNNEDDLK | 536 | P50748 | |
| QETITNAETAKEWFL | 216 | P06744 | |
| VADSQAEAKLSSFWQ | 501 | Q92616 | |
| INLKSNALWDESDDS | 636 | Q2M2Z5 | |
| LDSKAQQTELEWISS | 36 | Q15375 | |
| EASKEAALANQEVWE | 321 | Q9BT25 | |
| NVSDENSWKSEAEID | 481 | O94916 | |
| AVDRTVNDWTSSNEK | 2996 | O95613 | |
| DDTDNFDWTKQSTAT | 761 | Q7Z553 | |
| NDATTAAEEAEALQW | 5246 | Q9UPN3 | |
| LEKWLNDAENLSSDS | 346 | P14859 | |
| ASLQWFNQALEDKSD | 126 | A6NF01 | |
| DSRQLENKDVSSDWQ | 406 | Q9UBK2 | |
| EDRSISDKQQWDAAI | 731 | O60313 | |
| TAQSRKKWAEEFNDE | 2091 | P46100 | |
| TTSEADKNLSKQAWD | 191 | Q6UUV9 | |
| DAQTEWDLNSLSTKE | 226 | Q9P218 | |
| SVDNSEEWKDVFISS | 1421 | Q8TD84 | |
| EQEWQTPELSADKEF | 186 | Q6IN97 | |
| QEWQTPELSADKEFT | 1176 | Q68DX3 | |
| NDKESEAQISWFAPE | 106 | Q9H2U1 | |
| KNISDDSDFEWLSQL | 1256 | Q8WXX0 | |
| TWNLFKEDSVSRDLE | 21 | O14879 | |
| QNLEDWEEAIFDKST | 61 | Q9BQA9 | |
| ENLKDASSFLAEWQN | 351 | P08195 | |
| NTKKLDNSEDDLEFW | 236 | Q86X45 | |
| KSAQEWNLEIESTFD | 226 | O00462 | |
| WNLEIESTFDVVSSK | 231 | O00462 | |
| SFEDLTEESKTLAWN | 601 | Q92636 | |
| SSSEESENAEKWNKT | 221 | P56915 | |
| DFTLEEWQQLDSAQK | 16 | Q5JUW0 | |
| ENQEVKEWDFQSSLV | 421 | Q9NYC9 | |
| VTISESFNENLWGKE | 3141 | Q8NDH2 | |
| QEENFWSQALEDLET | 886 | Q9Y3R0 | |
| SVDWKVVDDVSNQTS | 281 | O75462 | |
| VDKIESIWSNLFNDS | 1151 | Q8IVF4 | |
| VEKWTQSSSSAFLEE | 3441 | Q9NZJ4 | |
| EWAVFTDDIDQFKTQ | 31 | Q8IZU8 | |
| AFASSTDQSEDKIWT | 301 | Q96CX2 | |
| FKDTFVNWNDELSLQ | 901 | Q8TDX9 | |
| KNAATEDLWESLENA | 471 | P55786 | |
| VFSNTLDTLSEIEWN | 471 | Q02224 | |
| DSTWNQTNKIFTDER | 206 | Q8N5C7 | |
| EWITFTEQSQLEADK | 516 | Q8NG08 | |
| SDWTLDPQELESKFN | 191 | Q6YP21 | |
| NEKNDKDSWSQLFTE | 276 | Q9H7T9 | |
| EIFSEASWEQVDKQD | 1096 | Q13615 | |
| WKALSEFALQSDLDQ | 301 | Q96A47 | |
| NASLENREWFSSKVD | 1561 | Q9H1H9 | |
| DTKNEDWDRIISSFI | 491 | Q9NXL9 | |
| WSASEASLFEEALEK | 271 | Q9BTC8 | |
| DQLDWIVNKFKEDSS | 371 | Q13416 | |
| EENLADWYSQVITKS | 1021 | P07814 | |
| EIDSKNIADAWSSSE | 661 | Q8WUY3 | |
| EDESRAWDSLNESNK | 1711 | Q8WUY3 | |
| ESAESSSNWEKQESI | 241 | Q9H4L7 | |
| TNSILFDSDDNIKWV | 1041 | Q14DG7 | |
| LTDATVWKDAATQIF | 461 | Q9Y345 | |
| KQSSAESDAWVLQFA | 221 | Q13394 | |
| SQWEFEKDELTQECA | 856 | Q8N4C6 | |
| SVESEVSQKSLWNYD | 281 | P21675 | |
| QSEANWAAEFAELEK | 561 | O00291 | |
| VNDFWAEISESVDKI | 31 | Q99460 | |
| DWLDFSSTNVEKADK | 216 | Q969V4 | |
| ASATKAEDDSFLQWV | 51 | Q15526 | |
| TAAKVASWDFVEATQ | 406 | Q9UHV7 | |
| LSEKLVAEWFSQAAD | 1426 | Q9UHV7 | |
| WVSKHSQDFETNDEL | 961 | Q13972 | |
| TSDVLSWNEVERAFK | 586 | Q6Q759 | |
| STKVSEEAESQQQWD | 2106 | Q01082 | |
| FWSQTQKTDHVALED | 441 | O94911 | |
| IFSFSADSELEKEQW | 506 | Q96P48 | |
| SSVAQTVDDFLLEKW | 1346 | Q9UPV0 | |
| ENSSDLNKSIWDEFI | 41 | Q9NY35 | |
| LNKSIWDEFISDEAD | 46 | Q9NY35 | |
| EVADAQRQAKDWASE | 886 | Q9P2M7 | |
| STWEVISNSEDFKNT | 271 | Q14CN2 | |
| EVDEQNDASSLWTKT | 91 | Q8NA57 | |
| NWKVATDERSAESSE | 276 | Q6ZUT1 | |
| ASFWTAEEVDLSKDL | 61 | Q7LG56 | |
| VASTDWQDIDQASFK | 41 | Q53QW1 | |
| DLWAEQDIKDSFQEA | 116 | Q8IYN0 | |
| SSELDAVENQLKWAS | 166 | P17028 | |
| EEFSWLQNTNESKIE | 1011 | O14709 | |
| TEDWNEDLSETKIFT | 246 | Q14157 | |
| LNEFWSSDSQDKAEA | 41 | Q5GAN6 | |
| TIDNRSSWENIKFED | 71 | Q9Y5K1 | |
| SSWENIKFEDSVGLQ | 76 | Q9Y5K1 | |
| KAEASFWTAEEVDLS | 96 | P31350 | |
| ESSTDLEELKNADWA | 256 | Q08AE8 | |
| QQFFRDSDELKSWVN | 576 | Q13813 | |
| EKELTSELNSWDSKQ | 771 | Q9BX26 | |
| AATAASFTAEEWEKI | 81 | Q07617 | |
| VTATWTLQDNFDKHD | 371 | Q3MJ13 | |
| ASEIKETNDTWNSQF | 201 | Q7Z5K2 | |
| WKENPVEFDSLFNES | 116 | O95427 | |
| SWSVDVDFTDLSENL | 806 | Q8NB14 | |
| KTSALSDETKNNWEV | 801 | P78527 | |
| SDETKNNWEVSALSR | 806 | P78527 | |
| EADLSSKQAAEEVWA | 306 | Q96SK2 | |
| TQAEKAVANFDRTEW | 196 | Q53FD0 | |
| ILATSSQDNSVKFWD | 206 | Q6PJI9 | |
| TFEDVAVKFTQEEWN | 16 | E7ETH6 | |
| DVAKDSWAAELENSS | 41 | Q9Y6X8 | |
| SWAAELENSSKENEV | 46 | Q9Y6X8 | |
| KWFALQIDESSEISN | 906 | O95789 | |
| KKDSDRNEQLSQWDS | 2951 | Q7Z7G8 | |
| SQESNKISQDSESWV | 546 | Q86YA3 | |
| NSKLLDSSEDVFETW | 936 | Q9UL62 | |
| TEHQLKQFTEDWSEE | 321 | Q8N9V3 | |
| EEKQTSWKEIDNDFT | 251 | Q9BXT5 | |
| SWKEIDNDFTNETKI | 256 | Q9BXT5 | |
| SQLDADSWIENDSLS | 1176 | P48553 | |
| KFWDFELVKDENSTQ | 521 | Q9UNX4 | |
| DFTLEEWQQLDSAQK | 16 | Q2M3X9 | |
| SITGEFLKEDNSWEN | 311 | Q86XD8 | |
| KNVWSFLKVNFEDDS | 471 | O94979 | |
| SADSASRKQEVQAWD | 156 | P45974 | |
| FAQDLWSEQSIKDSF | 81 | Q5JVG8 | |
| EEVDQTKNSNWESSA | 751 | Q9UPQ9 | |
| VNFTLEEWALLDSSQ | 11 | P17017 | |
| EVANSDSEFVNSWKD | 2086 | Q9Y493 | |
| SASEIKFDSQEDLWT | 51 | Q99612 |